|
Anguita-Gamez M, Vivas D, Ferrandis R, Esteve-Pastor MA, Marin F, Anguita Sanchez M; REQXAA study investigators. Periprocedural use of antithrombotic therapy in interventional cardiology in Spain: are we doing better than other specialties? Rev Esp Cardiol (Engl Ed). 2024 Aug;77(8):701-703. doi: 10.1016/j.rec.2024.02.017. Epub 2024 Apr 3. No abstract available. English, Spanish. PubMed PMID: 38580142.
AÑO: 2024; IF: 4.9
|
38580142
|
Roldan V, Soler-Espejo E, Marin F. Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved. Thromb Haemost. 2024 Apr;124(4):337-339. doi: 10.1055/s-0043-1775582. Epub 2023 Sep 11. No abstract available. PubMed PMID: 37696302.
AÑO: 2024; IF: 4.3
|
|
Piqueras-Sanchez C, Esteve-Pastor MA, Moreno-Fernandez J, Soler-Espejo E, Rivera-Caravaca JM, Roldan V, Marin F. Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation. Expert Rev Neurother. 2024 Sep;24(9):913-928. doi: 10.1080/14737175.2024.2379413. Epub 2024 Jul 22. PubMed PMID: 39039686.
AÑO: 2024; IF: 3.4
|
|
Soler-Espejo E, Rivera-Caravaca JM, Bru-Canovas JD, Esteve-Pastor MA, Lip GYH, Marin F, Roldan V. Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study. Intern Emerg Med. 2024 Oct;19(7):1941-1948. doi: 10.1007/s11739-024-03701-9. Epub 2024 Jul 4. PubMed PMID: 38965203; PubMed Central PMCID: PMC11467067.
AÑO: 2024; IF: 3.8
|
|
Serna MJ, Rivera-Caravaca JM, Lopez-Galvez R, Soler-Espejo E, Lip GYH, Marin F, Roldan V. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients. Rev Esp Cardiol (Engl Ed). 2024 Oct;77(10):835-842. doi: 10.1016/j.rec.2024.02.011. Epub 2024 Mar 7. English, Spanish. PubMed PMID: 38460882.
AÑO: 2024; IF: 4.9
|